Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) is among the most promising biotech stocks to buy according to hedge funds.
Alnylam Pharma ( ($ALNY) ) has issued an update. On September 30, 2025, Alnylam Pharmaceuticals entered into a Credit Agreement with Bank of ...
The company was one of many to get letters last month from the US Food and Drug Administration calling out what the agency ...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) ranks among the best biotech stocks to buy. RBC Capital maintained its Outperform rating for Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) on September 19 and ...
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY), a leading biotech company specializing in RNA interference (RNAi) therapeutics, ...
Alnylam Pharmaceuticals ( NASDAQ: ALNY) has pulled a television ad for its drug Amvuttra (vutrisiran) after the U.S. FDA determined the spot was misleading. Amvuttra is approved for two heart ...
Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) is one of the best performing large cap stocks to buy. On September 29, Alnylam ...
Alnylam joins Illumina and NashBio’s Alliance for Genomic Discovery to expand its 250,000 genome dataset and fuel RNAi research.
Transcription factors are the most powerful genes in our body. They are master regulators and have been implicated in our biggest diseases, even aging itself. Yet, many in the pharmaceutical industry ...
George Tidmarsh, head of the FDA’s Center for Drug Evaluation and Research, wrote that the ad incorrectly suggested patients "can be carefree" about their heart condition and "misleadingly suggests ...
Trump, who has long promised import taxes on pharmaceutical drugs, took to Truth Social on Thursday reiterating his intent to ...